Phase II Trial: The Combination of Tacrolimus, Sirolimus, and Rabbit Anti-Thymocyte Globulin (Thymoglobulin® Thymo) to Prevent Acute Graft-vs.-Host Disease (aGVHD) in Patients Receiving Unrelated Hematopoietic Stem Cell Transplantation (UHSCT)
作者
Zaid Al‐Kadhimi,Zartash Gul,R. Rodríguez,W. Chen,Anna Mitchell,Muneer H. Abidi,Lois Ayash,Abhinav Deol,L G Lum,Voravit Ratanatharathorn,Joseph P. Uberti